Objective and subjects: Dietary ®bre has been suggested to interfere with endogenous cholesterol synthesis in the liver. Therefore the effects of oat bran on the proportions of cholesterol synthesis precursors (squalene, D 8 -cholestenol, desmosterol and lathosterol), cholestanol and plant sterols (campesterol and beta-sitosterol) to cholesterol were analysed in serum of 36 hypercholesterolaemic subjects. Design: A randomized study of eight weeks duration where beta-glucan-rich oat bran (n 20, subjects) or wheat bran (n 16) was used as a part of a cholesterol lowering diet. Plant sterols and cholesterol synthesis precursors were analysed from frozen samples afterward. Results: In the oat-bran group, but not in the wheat bran group, serum total cholesterol declined transiently. The proportions of plant sterols and cholestanol in serum, which re¯ect cholesterol absorption ef®ciency were unchanged. However, the proportions of squalene appeared to be transiently increased during the study. Subjects with apolipoprotein E 4 allele had higher serum campesterol and sitosterol levels (suggestive of ef®cient cholesterol absorption) than those with homozygous apolipoprotein E 3 allele. Conclusions: Since the cholesterol precursors in serum re¯ecting endogenous cholesterol synthesis remained almost unchanged the reduction in the serum cholesterol level by oat bran treatment can not be ascribed to an inhibition of the endogenous cholesterol synthesis.
Introduction
Several studies have shown that soluble dietary ®bres, for example plant gums (Anderson, 1985; Jenkins et al, 1979; Miettinen, 1987; Todd et al, 1990; Tuomilehto et al, 1988; Uusitupa et al, 1989) and oat bran Davidson et al, 1991; DemarkWahnefried et al, 1990; DeGroot et al, 1963; Van Horn et al, 1986; Van Horn et al, 1991; Judd & Truswell, 1981; Kestin et al, 1990; Kirby et al, 1981) lower serum total and LDL-cholesterol levels. The main soluble ®bre portion of oat bran is beta-glucan (A Ê hman et al, 1987) . As to the mechanisms of action of soluble dietary ®bre products, two main theories have been presented; it has been shown that certain dietary ®bres promote the excretion of cholesterol as bile acids in the stool thereby upregulating LDL receptor activity Miettinen & Tarpila, 1989; Turner et al, 1990) . According to the other theory, fermentation of dietary ®bre in colon results in the formation of short chain fatty acids which may have an inhibitory effect on hepatic cholesterol synthesis (Anderson, 1985; Chen W-JL et al, 1984) . Cholesterol synthesis precursors in serum re¯ect cholesterol synthesis Fa Èrkkila È & Miettinen, 1990; Kempen et al, 1988; Miettinen, 1970 Miettinen, , 1985a Miettinen et al, , 1990 Vuoristo & Miettinen, 1986) , while serum plant sterols and to some extent cholestanol re¯ect absorption and biliary elimination of sterols Fa Èrkkila È & Miettinen, 1990; Miettinen et al, 1990; Tilvis & Miettinen, 1986 ). In our previous study, we found attenuation of hypocholesterolaemic in¯uence of beta-glucan-rich oat bran with time (Uusitupa et al, 1992a) . This ®nding stimulated us to analyse cholesterol synthesis precursors and plant sterols during treatment with oat-bran to elucidate the mechanism of action, and to ®nd out whether changes in these variables could explain an elevation of serum cholesterol during prolonged use of oat bran (Uusitupa et al, 1992b) .
Subjects and methods
Forty-six subjects with known elevated serum total cholesterol (5.5±8.5 mmol/l) were originally recruited for the study (Uusitupa et al, 1992a) . At the screening phase three subjects had serum total cholesterol`5.5 mmol/l, and were therefore excluded. Two subjects refused to participate for personal reasons. Three subjects in the wheat bran group dropped out during the ®rst two weeks due to abdominal symptoms considered not related to wheat bran. Two subjects in the oat bran group discontinued the study, one because of operation of breast tumor and one because of gastrointestinal infection. Thus 36 subjects ®nished the study, 20 in the oat bran group and 16 in the wheat bran group. There were 10 men and 10 women in the oat bran group. Their mean age was 50 AE 6 y and mean body mass index 26.3 AE 3.3 kg/m 2 . The wheat bran group consisted of 10 men and 6 women aged 45 AE 9 y with the mean body mass index of 26.7 AE 2.5 kg/m 2 . The body weight and body mass index remained stable throughout the study. All had been screened for secondary causes of hyperlipidaemias, and none had antihyperlipidaemic drugs, thyroid, renal or liver disease, abuse of alcohol or diabetes mellitus. Five subjects (1 in the oat bran and 4 in the wheat bran group) were treated with beta-blockers (acebutolol, metoprolol, atenolol, sotalol, timolol) and 5 (3 and 2, respectively) with diuretics (hydrochlorothiazide, or triamteren) for coronary heart disease or hypertension. Altogether four women were receiving menopausal hormone therapy (3 in the oat bran and 1 in the wheat bran group). Each patient gave informed consent for the study and the study was approved by the Ethics Committee, University of Kuopio.
Study design
A four week run-in period preceded the study. At the beginning of the run-in period, medical histories were obtained. Clinical examination included blood pressure, body weight and height; a 12 h overnight venous blood sample was taken. Dietary instructions of the lipid-lowering AHA 1 diet were reinforced by clinical dietitians (The Expert Panel, 1988) .
At baseline (0 weeks) the subjects were randomly allocated into the oat bran or wheat bran groups, and the study was carried out with a double-blind study design, except for dietitians who had to know the two groups. The study lasted eight weeks, and subjects visited the clinical research unit after randomisation at two, four and eight weeks. At 0, 4 and 8 week visits food records were received, body weight was obtained and a 12 h overnight fasting venous blood sample was taken. At every visit, serum total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and cholesterol synthesis precursors, cholestanol and plant sterols were determined.
Bran products
Both oat bran and wheat bran preparations (supplied by Alko Ltd, Helsinki, Finland) were packed in identical sachets of similar volume (200 ml). During the ®rst two weeks each subject increased the daily dose stepwise to the whole sachet or the highest tolerable dose. The total ®bre content of added wheat bran was 20.5 g and that of oat bran 29.8 g, which included 10.3 g of beta-glucan.
The oat bran product enriched with beta-glucan (Alko Ltd, Helsinki, Finland) consisted of 10.3 g of fat, 23 g of starch, 20.9 g of protein and 48.1 g of dietary ®bre totally (16.6 g of beta-glucan) in 100 g of dry material.
Dietary instructions and food records
Subjects received detailed written instructions at the beginning of the run-in period to reinforce the principles of the AHA 1 diet (30%, 10:10:10 indicating percents of calories derived from total fat and saturated:monounsaturated: polyunsaturated fat). Detailed instructions concerning the diet have been presented elsewhere (Uusitupa et al, 1992a) . Adherence to dietary instructions was followed during the study by repeated dietary records. Subjects kept food records by household measures for four days during the run-in period and before visits at four and eight weeks. The nutrient composition of diets was calculated using the Nutrica nutrient calculation program based on a database at the Finnish Social Insurance Institute (Rastas et al, 1989) .
Methods
Weight was measured in the morning with light clothes by an electrical weighing machine. An enzymatic method was used to determine cholesterol (Ro Èschlau et al, 1974) . The Apo E phenotype was determined from the plasma after delipidation by isoelectric focusing and immunoblotting technique using commercial antibodies (Menzel & Uterman, 1986; Enholm et al, 1986) . Serum total levels of cholesterol precursors, squalene, D 8 -cholestenol, lathosterol and desmosterol, serum total plant sterols, campesterol and beta-sitosterol, and cholestanol were quantitated with gasliquid chromatography (GLC) on a 50 m long SE-30 capillary column as described in detail elsewhere (Miettinen, 1985; Miettinen & Koivisto, 1983) . In the results the serum levels of squalene and non-cholesterol sterols are given as proportions to cholesterol. This expression seems preferable for the precursors at least, because reduction of LDL which transports most of non-cholesterol sterols, could also reduce precursor levels even in the absence of reduced cholesterol synthesis. Thus a reduced precursor/cholesterol ratio can be considered to re¯ect diminished synthesis while an increase of the ratio suggests enhanced synthesis.
Statistical analyses were performed using the SPSS-Xprogram (SPSS Inc, 1988) . Multivariate analysis of variance (MANOVA) for repeated measures was used to ®nd out the differences between the groups and the changes within the groups. The results of baseline, four and eight weeks were included in ®nal analyses. If there were no statistically signi®cant overall changes within the groups or differences between the groups in MANOVA, no further analyses were conducted. Due to the small number of subjects in the subgroups, analyses were carried out with Wilcoxon's (paired samples) and Mann-Whitney's test (unpaired samples), respectively. Pearson's correlation coef®cients were calculated for some pairs of interest. The results are given as means AE s.d. All P-values are two-sided.
Results
Six subjects in the oat bran group reduced the daily dose during the study, and two subjects could not increase the dose to the target level. The reduction in serum total cholesterol was greater in those who used at least twothirds of the planned dose of oat bran than in other subjects (Uusitupa et al, 1992a) .
There were no signi®cant differences between the oat bran and wheat bran groups in energy intake, or in the intake of energy nutrients, dietary ®bre and cholesterol during the study. Wheat bran group had a small but signi®cant decline in ®bre intake from food (added ®bre not included) during the study from 24.4 AE 5.5 to 19.0 AE 6.4g (P`0.001), and a marginal increase in monoenes and decrease in proteins, but otherwise no signi®cant changes were found in the composition of the diets in either group during the study. Table 1 shows the dietary data at eight weeks by group. Detailed data on the diets have been reported previously (Uusitupa et al, 1992a) . The total ®bre intake, including the added ®bre was 51g for the oat bran group and 40g for the wheat bran group, assumed that the whole daily dose of ®bre product was taken. After taking into account the energy of oat bran product used, the total energy intake was 7041 KJ, fat intake 33.6%, carbohydrate intake 46.9% and that of protein 19.5% in the oat bran group (NS as compared to the wheat bran group). Table 2 gives the results on serum total cholesterol, cholesterol synthesis precursors, cholestanol and plant sterols at baseline, and at four and eight weeks. In the oat bran group serum total cholesterol declined signi®cantly during the ®rst four weeks due to a decease in LDLcholesterol level (not shown), but at eight weeks serum total cholesterol did not differ from the baseline level. In the wheat bran group no signi®cant changes were observed in serum lipids. In both groups serum squalene/cholesterol ratio was increased at four weeks, but at eight weeks it was declined to the initial level. The lathosterol/cholesterol ratio in the oat bran group was nonsigni®cantly higher at eight weeks than at the baseline, but otherwise the concentrations of cholesterol synthesis precursors, cholestanol and plant sterols remained unchanged.
Correlations between the changes induced by the oat bran during the ®rst four weeks in serum cholesterol and cholesterol precursors were insigni®cant. The respective correlations of cholestanol with cholestenol (r 70.60, P`0.05), desmosterol (r 70.31, NS) or lathosterol (r 70.66, P`0.01) were inverse, whereas positive correlations were found between the changes in the cholesterol synthesis precursors: cholestenol vs desmosterol (r 0.79, P`0.001), cholestenol vs lathosterol (r 0.66, P`0.01), and desmosterol vs lathosterol (r 0.35, NS). The respective changes in squalene values were not related to the other cholesterol synthesis precursors or cholestanol.
We also analysed the variables according to apolipoprotein E phenotypes in the whole group at the baseline (Table  3) , and in the oat bran group separately during the study. The proportion of desmosterol but not that of other precursors was signi®cantly lower in the subjects with apo E 4 allele (E 4/4 or 4/3), whereas cholestanol, campesterol and sitosterol were higher in the subjects with apo E 4 allele than in those with apo E 3/3.
In subjects with apo E4 allele the lathosterol/cholesterol ratio was 155 AE 57 and 176 AE 52 (NS) at baseline and at eight weeks, respectively, while these ®gures were 163 AE 52 and 170 AE 53 in subjects with Apo E 3/3 (NS).
Discussion
After capillary columns became available for the measurement of non-cholesterol sterols (Miettinen & Koivisto, 1983) , the determinations of demethylated precursors of cholesterol in serum have been applied to study the endogenous cholesterol synthesis in different clinical situations (Fa Èrkkila È & Miettinen, 1990; Kempen et al, 1988; Miettinen, 1985; Miettinen & Koivisto, 1983) . In the present study, oat bran was compared with the wheat bran since the latter ®bre has been known to be neutral regarding the effects on serum cholesterol concentration. There was a temporary increase in the concentration of squalene both in the oat bran and wheat bran groups, even though in the former studies squalene has not been proven to be an accurate, long-term measure for endogenous cholesterol synthesis. From the other precursors of cholesterol, lathosterol and to some extent also D 8 -cholestenol and desmosterol, have been used for evaluation of the whole body cholesterol synthesis Fa Èrkkila È & Miettinen, 1990; Kempen et al, 1988; Miettinen, 1970 Miettinen, , 1985 Miettinen et al, , 1990 Miettinen & Vuoristo & Miettinen, 1986) . It has been shown that serum lathosterol positively correlates with hepatic HMG-CoA reductase activity in humans (Bjo Èrkheim et al, 1987) . Furthermore, the lathosterol/cholesterol ratio decreases by HMG-CoA reductase inhibitors (Kempen et al, 1988; Vanhanen et al, (Gylling et al, 1989) and guar gum, even in the presence of lovastatin (Uusitupa et al, 1992b) . In the present study, lathosterol/cholesterol ratio did not change signi®cantly by the oat ban treatment. By contrast, the results obtained by plantago ovata and guar gum preparations (Miettinen & Tarpila, 1989; Uusitupa et al, 1992b) suggest that the endogenous cholesterol synthesis could be increased by some soluble ®bre products.
Positive correlations have been reported between cholesterol absorption ef®ciency and serum proportions of cholestanol, (the 5-a-saturated derivative of cholesterol), campesterol and sitosterol . In the present study, the levels of these variables remained unchanged. This suggests that the two ®bre products did not interfere with the absorption of cholesterol in a signi®cant manner, a ®nding proposed for soluble ®bres (Miettinen, 1987; Miettinen & Tarpila, 1989) .
As in some previous studies (Kesa Èniemi et al, 1987; Miettinen & Kesa Èniemi, 1988) , the cholestanol and plant sterol ratios to cholesterol were higher in subjects with apo E 4/4 or 4/3 phenotypes than in those with Apo E 3/3. Cholesterol synthesis precursors, especially the desmosterol/cholesterol ratio, were on the other hand decreased in subjects with apo E 4/4 or 4/3, a ®nding re¯ecting a diminished endogenous cholesterol synthesis in subjects with apo E 4/4 or 4/3 (Kesa Èniemi et al, 1987) . Because high plant sterol and cholestanol proportions in serum re¯ect an ef®cient absorption of dietary cholesterol (Tilvis & Miettinen, 1986; Miettinen et al, , 1990 , the data are consistent with previous observations which suggest that apo E polymorphism may affect the ef®ciency of cholesterol absorption (Kesa Èniemi et al, 1987; Miettinen & Kesa Èniemi, 1988) and subsequently cholesterol synthesis; the higher the absorption the lower the synthesis of endogenous cholesterol. Since the ®bres used in this study obviously had little effect on cholesterol absorption no consistent change was observed even in the subjects with high cholesterol absorption associated with Apo E 4 allele.
A high serum level of cholestanol, the 5-a-saturated derivative of cholesterol, re¯ects high ef®ciency of intestinal sterol absorption, and is accordingly inversely related to endogenous cholesterol synthesis and fecal excretion of neutral sterols . Although no signi®cant changes were observed in the mean values of cholestanol and cholesterol synthesis precursors, the changes in the proportion of cholestanol were inversely correlated with those of the cholesterol precursors in the oat bran group. This ®nding con®rms an inverse relationship between the proportion of cholestanol in serum and cholesterol synthesis, but does not give further information regarding the mechanisms behind this ®nding.
Conclusions
Cholesterol synthesis precursors in serum remained almost unchanged during both the oat bran and wheat bran treatment. Neither oat bran nor wheat bran affected serum plant sterol levels in this study.
